AIP
ROIV icon

Ameritas Investment Partners’s Roivant Sciences ROIV Stock Holding History

Ameritas Investment Partners’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.94M Hold
83,064
– – 0.08% 259
2026
Q1 		$2.3M Buy
83,064
+2,419
+3% +$62.1K 0.07% 301
2025
Q4 		$1.75M Hold
80,645
– – 0.05% 381
2025
Q3 		$1.22M Sell
80,645
-1,095
-1% -$13.6K 0.04% 530
2025
Q2 		$921K Sell
81,740
-1,093
-1% -$11.8K 0.03% 639
2025
Q1 		$836K Sell
82,833
-3,192
-4% -$34.5K 0.03% 658
2024
Q4 		$1.02M Sell
86,025
-3,490
-4% -$41.3K 0.03% 624
2024
Q3 		$1.03M Buy
89,515
+17,526
+24% +$200K 0.03% 621
2024
Q2 		$761K Sell
71,989
-2,411
-3% -$26.4K 0.03% 686
2024
Q1 		$784K Buy
+74,400
New +$802K 0.03% 688

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Ameritas Investment Partners's ROIV Position: Q2 2026 in Review

Ameritas Investment Partners held its Roivant Sciences (ROIV) position steady in Q2 2026 at 83,064 shares worth $2.94M. The position accounts for 0.08% of the portfolio, ranked #259.

Ameritas Investment Partners first reported a position in ROIV in Q1 2024 and has held it in 10 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Ameritas Investment Partners held 83,064 shares of Roivant Sciences worth $2.94M as of Q2 2026.
  • Ameritas Investment Partners left its Roivant Sciences share count unchanged in Q2 2026.
  • Roivant Sciences made up 0.08% of Ameritas Investment Partners's portfolio in Q2 2026, its #259 holding.
  • Ameritas Investment Partners first reported a position in Roivant Sciences in Q1 2024 and has held it in 10 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.